Literature DB >> 16391916

Schizencephaly with occlusion or absence of middle cerebral artery.

A Fernández-Bouzas1, T Harmony, E Santiago-Rodríguez, J Ricardo-Garcell, T Fernández, D Avila-Acosta.   

Abstract

In a study of 160 infants with prenatal and/or perinatal risk factors for brain damage, we observed three cases of schizencephaly. All cases were unilateral, and the clefts had open lips. In two cases, magnetic resonance angiography showed occlusion or absence of the middle cerebral artery (MCA) on the affected side. Two of the patients, including one with absent flow in the MCA of the affected side, had ipsilateral cerebellar atrophy.

Entities:  

Mesh:

Year:  2006        PMID: 16391916     DOI: 10.1007/s00234-005-0006-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  25 in total

1.  Schizencephalies; a study of the congenital clefts in the cerebral mantle; clefts with hydrocephalus and lips separated.

Authors:  P I YAKOVLEV; R C WADSWORTH
Journal:  J Neuropathol Exp Neurol       Date:  1946-07       Impact factor: 3.685

2.  Schizencephalies; a study of the congenital clefts in the cerebral mantle; clefts with fused lips.

Authors:  P I YAKOVLEV; R C WADSWORTH
Journal:  J Neuropathol Exp Neurol       Date:  1946-04       Impact factor: 3.685

3.  Brain injuries in early foetal life: consequences for brain development.

Authors:  J Mancini; V Lethel; C Hugonenq; B Chabrol
Journal:  Dev Med Child Neurol       Date:  2001-01       Impact factor: 5.449

4.  Experimental schizencephaly induced by Kilham strain of mumps virus: pathogenesis of cleft formation.

Authors:  T Takano; S Takikita; M Shimada
Journal:  Neuroreport       Date:  1999-10-19       Impact factor: 1.837

5.  Schizencephaly: correlations of clinical and radiologic features.

Authors:  A M Packard; V S Miller; M R Delgado
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

6.  Sporadic neonatal schizencephaly associated with brain calcification.

Authors:  A M al-Alawi; K I al-Tawil; M M al-Hathal; I Amir
Journal:  Ann Trop Paediatr       Date:  2001-03

7.  Congenital schizencephaly associated with in utero warfarin exposure.

Authors:  S Pati; G D Helmbrecht
Journal:  Reprod Toxicol       Date:  1994 Mar-Apr       Impact factor: 3.143

Review 8.  Magnetic resonance imaging in developmental disorders of the cerebral cortex.

Authors:  R I Kuzniecky
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

9.  The CT and MR evaluation of migrational disorders of the brain. Part II. Schizencephaly, heterotopia and polymicrogyria.

Authors:  S E Byrd; R E Osborn; T P Bohan; T P Naidich
Journal:  Pediatr Radiol       Date:  1989

10.  Schizencephaly, consequence of a developmental vasculopathy? A clinicopathological report.

Authors:  P Landrieu; C Lacroix
Journal:  Clin Neuropathol       Date:  1994 Jul-Aug       Impact factor: 1.368

View more
  4 in total

1.  Early cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanol.

Authors:  Stefania Bassanini; Kerri Hallene; Giorgio Battaglia; Adele Finardi; Stefano Santaguida; Marilyn Cipolla; Damir Janigro
Journal:  Neurobiol Dis       Date:  2007-03-03       Impact factor: 5.996

Review 2.  Hypoxia: A teratogen underlying a range of congenital disruptions, dysplasias, and malformations.

Authors:  Aaron P Adam; Kurlen S E Payton; Pedro A Sanchez-Lara; Margaret P Adam; Ghayda M Mirzaa
Journal:  Am J Med Genet A       Date:  2021-05-03       Impact factor: 2.802

3.  Schizencephaly-diagnostics and clinical dilemmas.

Authors:  Agata Halabuda; Lukasz Klasa; Stanislaw Kwiatkowski; Lukasz Wyrobek; Olga Milczarek; Aleksandra Gergont
Journal:  Childs Nerv Syst       Date:  2015-02-18       Impact factor: 1.475

4.  Unilateral Open-lip Schizencephaly with Tonsillar Herniation in a Preterm Infant.

Authors:  Juan Carlos Gonzalez; Kanya Singhapakdi; Anthony M Martino; Bassam H Rimawi; Ramachandra Bhat
Journal:  J Pediatr Neurosci       Date:  2019-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.